As 2013 rolls in, Express Pharma presents insights from industry experts on the sector’s performance in 2013
‘Empowered Patients’: A changing dynamic
– Tapan J Ray, Director General, Organisation of Pharmaceutical Producers of India
Indian pharmaceutical industry— growth intact amid current headwinds faced by industry
– Hitesh Sharma, Partner & National Leader – Life Sciences, Ernst & Young
Adapting to the evolving consumer landscape
– Ankit Suri, Vice President, Tecnova India
Indian pharmaceuticals: A long-term story
– Anjan Sen, Director, Deloitte Touche Tohmatsu India
Improved awareness will lead to better business
– Dr Kiran Marthak, Vice Chairman, Medical Sub Committee- IDMA and Head Global Clinical Development, Lambda Therapeutic Research
Indian clinical research: A call to self regulate
– Hemant Rehani, Vice President and Head—Clinical Development Services, India and Sri Lanka, Quintiles
Indian pharma: Emerging as global power in R&D
– DK Aggarwal, CMD, SMC Investments and Advisors
Tech solutions to improve management of drug development programmes
– Ted Gastineau, President, ICON Clinical Research
IPR trends in 2013: An alloy of problems and solutions
– Milind Sathe, Deputy General Manager-Projects, Unichem Laboratories
Transformational change in 2013
– Dr RB Smarta, Founder and Managing Director, Interlink Marketing Consultancy
Modest progress in fiscal and public sector reforms expected
– Abhishek Goenka, Founder & CEO, India Forex Advisors